Biotechnology Firm Claims Mylan Breached Agreements In Singapore Arbitration

(January 6, 2016, 9:44 AM EST) -- MELBOURNE, Australia — An Australian biotechnology company on Jan. 6 announced that it has commenced arbitration in Singapore against a laboratory.

Phosphagenics Limited said in a news release that it filed notices of arbitration against Mylan Laboratories Limited, a wholly owned subsidiary of Mylan Inc., with the Singapore International Arbitration Centre.

Research Agreement

Phosphagenics said it and Agila Specialties Private Limited entered into a master research agreement and a licensing agreement to develop and commercialize a formulation that combined Phosphagenics' proprietary TPM® technology with the injectable...
To view the full article, register now.